Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
By Michelle F. Davis, Vinicy Chan and Crystal Tse ยท Bloomberg Markets
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.